VAERS Explorer
Back to explore

Report #2857398

Received Sep 8, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1UNK—

Symptoms (1)

Swelling face

Symptom narrative

swelling on face; This non-serious case was reported by a consumer via call center representative and described the occurrence of facial swelling in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced facial swelling (Verbatim: swelling on face). The outcome of the facial swelling was resolved. It was unknown if the reporter considered the facial swelling to be related to Shingrix. It was unknown if the company considered the facial swelling to be related to Shingrix. Linked case(s) involving the same patient: US2025104007; Sender's Comments: US-GSK-US2025104007:same patient